Establishment Labs Holdings ROA 2017-2025 | ESTA
Current and historical return on assets (ROA) values for Establishment Labs Holdings (ESTA) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Establishment Labs Holdings ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2025-09-30 | $-0.08B | $0.34B | -24.91% |
| 2025-06-30 | $-0.09B | $0.33B | -27.84% |
| 2025-03-31 | $-0.09B | $0.33B | -28.85% |
| 2024-12-31 | $-0.09B | $0.35B | -27.94% |
| 2024-09-30 | $-0.07B | $0.28B | -24.93% |
| 2024-06-30 | $-0.08B | $0.29B | -29.46% |
| 2024-03-31 | $-0.08B | $0.30B | -29.46% |
| 2023-12-31 | $-0.08B | $0.27B | -30.56% |
| 2023-09-30 | $-0.07B | $0.27B | -29.51% |
| 2023-06-30 | $-0.06B | $0.29B | -27.77% |
| 2023-03-31 | $-0.08B | $0.21B | -40.59% |
| 2022-12-31 | $-0.08B | $0.21B | -41.03% |
| 2022-09-30 | $-0.08B | $0.19B | -45.37% |
| 2022-06-30 | $-0.07B | $0.20B | -45.71% |
| 2022-03-31 | $-0.04B | $0.14B | -27.49% |
| 2021-12-31 | $-0.04B | $0.14B | -27.70% |
| 2021-09-30 | $-0.03B | $0.15B | -21.71% |
| 2021-06-30 | $-0.02B | $0.15B | -14.31% |
| 2021-03-31 | $-0.03B | $0.15B | -17.42% |
| 2020-12-31 | $-0.04B | $0.16B | -23.90% |
| 2020-09-30 | $-0.04B | $0.16B | -25.46% |
| 2020-06-30 | $-0.05B | $0.16B | -33.57% |
| 2020-03-31 | $-0.05B | $0.17B | -36.22% |
| 2019-12-31 | $-0.04B | $0.12B | -34.74% |
| 2019-09-30 | $-0.04B | $0.12B | -39.20% |
| 2019-06-30 | $-0.03B | $0.11B | -26.55% |
| 2019-03-31 | $-0.03B | $0.11B | -25.37% |
| 2018-12-31 | $-0.02B | $0.12B | -24.44% |
| 2018-09-30 | $-0.02B | $0.12B | -24.00% |
| 2018-06-30 | $-0.03B | $0.06B | -67.04% |
| 2018-03-31 | $-0.04B | $0.06B | -127.59% |
| 2017-12-31 | $-0.04B | $0.06B | -245.61% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $2.055B | $0.166B |
| Establishment Labs Holdings Inc. is a medical technology company. It focuses on designing, developing, manufacturing and marketing portfolio of silicone gel-filled breast implants ae well as body shaping implants. The company's brand consists of Motiva Implants(R) and MotivaImagine (R) platform. Its technologies portfolio includes Divina 3D Simulation System(R), Puregraft and MotivaImagine Centers (R). Establishment Labs Holdings Inc. is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $159.812B | 29.34 |
| HCA Healthcare (HCA) | United States | $111.062B | 18.39 |
| CVS Health (CVS) | United States | $96.007B | 11.04 |
| Elevance Health (ELV) | United States | $73.505B | 10.78 |
| Cencora (COR) | United States | $65.892B | 21.24 |
| Natera (NTRA) | United States | $33.751B | 0.00 |
| DiDi Global (DIDIY) | China | $24.867B | 20.32 |
| Labcorp Holdings (LH) | United States | $21.421B | 16.33 |
| Medpace Holdings (MEDP) | United States | $15.440B | 38.33 |
| ICON (ICLR) | Ireland | $15.010B | 14.89 |
| BioMerieux (BMXMF) | France | $14.822B | 0.00 |
| Solventum (SOLV) | United States | $14.818B | 14.38 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.851B | 0.00 |
| Viatris (VTRS) | United States | $12.589B | 4.69 |
| CochLear (CHEOY) | Australia | $11.653B | 0.00 |
| Revvity (RVTY) | United States | $11.427B | 21.04 |
| Charles River Laboratories (CRL) | United States | $9.071B | 17.47 |
| Caris Life Sciences,�Inc (CAI) | United States | $8.143B | 0.00 |
| HealthEquity (HQY) | United States | $8.075B | 30.19 |
| Sonic Healthcare (SKHHY) | Australia | $7.567B | 0.00 |
| Avantor (AVTR) | United States | $7.452B | 11.39 |
| BrightSpring Health Services (BTSG) | United States | $6.455B | 38.48 |
| Bausch + Lomb (BLCO) | Canada | $5.958B | 39.12 |
| PACS (PACS) | United States | $4.817B | 29.30 |
| Sotera Health (SHC) | United States | $4.759B | 22.94 |
| GeneDx Holdings (WGS) | United States | $4.595B | 80.69 |
| Alignment Healthcare (ALHC) | United States | $3.912B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.508B | 20.47 |
| Concentras Parent (CON) | United States | $2.495B | 15.58 |
| Surgery Partners (SGRY) | United States | $2.223B | 28.65 |
| Progyny (PGNY) | United States | $2.071B | 40.71 |
| Pediatrix Medical (MD) | United States | $1.900B | 11.34 |
| Organon (OGN) | United States | $1.856B | 1.96 |
| Teladoc Health (TDOC) | United States | $1.347B | 0.00 |
| Ardent Health (ARDT) | United States | $1.259B | 4.11 |
| Nutex Health (NUTX) | United States | $1.138B | 8.70 |
| Omada Health (OMDA) | $1.013B | 0.00 | |
| CareDx (CDNA) | United States | $0.953B | 15.57 |
| GoodRx Holdings (GDRX) | United States | $0.920B | 15.06 |
| Embecta (EMBC) | United States | $0.684B | 3.94 |
| InnovAge Holding (INNV) | United States | $0.682B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.578B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.559B | 0.00 |
| Pomdoctor - (POM) | China | $0.552B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| CryoPort (CYRX) | United States | $0.478B | 0.00 |
| Enhabit (EHAB) | United States | $0.472B | 21.20 |
| SBC Medicals (SBC) | United States | $0.385B | 7.08 |
| Strata Critical Medical (SRTA) | United States | $0.376B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.368B | 5.92 |
| QDM (QDMI) | Hong Kong, SAR China | $0.323B | 67.42 |
| So-Young (SY) | China | $0.315B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.313B | 0.00 |
| Oncology Institute (TOI) | United States | $0.298B | 0.00 |
| Agilon Health (AGL) | United States | $0.270B | 0.00 |
| KindlyMD (NAKA) | United States | $0.224B | 0.00 |
| Beauty Health (SKIN) | United States | $0.186B | 0.00 |
| LifeMD (LFMD) | United States | $0.168B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.127B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.119B | 0.00 |
| DocGo (DCGO) | United States | $0.103B | 0.00 |
| Biodesix (BDSX) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.047B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.036B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.023B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.021B | 6.33 |
| Basel Medical Group (BMGL) | Singapore | $0.020B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.019B | 0.00 |
| Lifeward (LFWD) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| ISpecimen (ISPC) | United States | $0.005B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |